3 ms·
I think it is because in blood drugs and gene based treatments are the only option, surgery is simply not an option. This has always spurred the blood cancer fi
by teekert 11y ago
I think it is because in blood drugs and gene based treatments are the only option, surgery is simply not an option. This has always spurred the blood cancer field to take greater risks, the all or nothing approach.
- erkkie 11y agoSurgery is an option, namely bone-marrow transplants. The reason blood cancers are first with these techniques boils down to having better known antigen targets to target compared to solid tumors where known antigens have more cross reactivity to other tissues (so less specificity, more side-effects).
- carbocation 11y agoDespite the word "transplant", bone marrow transplants are not done surgically; they are done by infusion of donor cells into the bloodstream. Then, the cells seek out their own niche and engraft.
- erkkie 11y agoGood point, you're right, not surgery, more like an (significantly invasive) procedure. Still good to differentiate from "giving a drug".
- pacap 11y agoFrom what I remember, these blood cancer have an antigen, CD13 or something, which is unique to them - no other body part has it, making it easy to target them. Otherwise, you get the side effect of destroying your own body, the case of a woman a few years ago, who died having her lungs destroyed by immunotherapy. Lungs had the same antigen. This morning I read something hopeful in this direction - UCSF researchers designed an AND gate, so now they could trigger a T cell attack only when 2 specific antigens are present, making it much more reliable. And I could imagine these can be chained, further narrowing it down. It needs genetic sequencing to isolate. https://www.ucsf.edu/news/2016/01/401471/tricked-out-immune-cells-could-attack-cancer-spare-healthy-cells https://www.ucsf.edu/news/2016/01/401471/tricked-out-immune-... At the moment this is a terrible manual and time consuming process, so it is expensive.
- erkkie 11y agoThis is also why a combination of engineered T-cells and immune checkpoint inhibitors is a really winning combo. http://www.theguardian.com/society/2015/jun/01/paradigm-shift-hailed-in-treatment-of-lung-cancer http://www.theguardian.com/society/2015/jun/01/paradigm-shif...
- AstralStorm 11y agoImmune checkpoint (fancy name that, you probably mean anti-autoimmune system) inhibitors main problem is the very high risk of autoimmune disorders that are hard or impossible to treat. Just toggling the suppressor will not kill clonal cells already in circulation, and those can last a long, long time, or even a lifetime. If you're unlucky, you will also get "broken" immune memory cells - which also last for life. Trading cancer for SLE or rheumatoidal arthritis etc.